» Articles » PMID: 32547207

With High-Risk Factors, Total Thyroidectomy is Preferred for Thyroid Cancer

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Jun 18
PMID 32547207
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Based on thyroid cancer data from patients treated in Liaocheng People's Hospital in 2017, with Chinese national and regional characteristics, in this study we addressed the controversy of which initial thyroid surgical mode, lobectomy or total thyroidectomy, is most effective.

Patients And Methods: Clinical and pathological data from 552 patients with thyroid cancer, who were initially diagnosed and treated surgically, were collected from the Department of Thyroid Surgery. Among them, 40 patients underwent endoscopic surgery, with resection including lobectomy + central lymph node dissection of the affected lobe, while 512 cases underwent total thyroidectomy + central lymph node dissection.

Results: The metastasis rate for all patients was 59.42%. Further, among patients with bilateral or multiple tumors or capsule invasion, the proportions who developed metastatic disease were 63.54% and 71.19% and 67.46%, respectively. Meanwhile, the incidence of contralateral accidental malignancy was 7.25% after postoperative paraffin pathology.

Discussion: Rates of neck lymph node metastasis are high, particularly among patients with risk factors for poor prognosis. It is recommended that, among patients with risk factors, initial treatment should comprise at least total thyroidectomy + central lymph node dissection in China, to avoid the risks associated with secondary surgery and effects on patient quality of life.

References
1.
Pathak K, Leslie W, Klonisch T, Nason R . The changing face of thyroid cancer in a population-based cohort. Cancer Med. 2013; 2(4):537-44. PMC: 3799288. DOI: 10.1002/cam4.103. View

2.
Yan L, Blanco J, Reddy V, Al-Khudari S, Tajudeen B, Gattuso P . Clinicopathological features of papillary thyroid microcarcinoma with a diameter less than or equal to 5 mm. Am J Otolaryngol. 2019; 40(4):560-563. DOI: 10.1016/j.amjoto.2019.05.003. View

3.
Wu X, Li B, Zheng C, He X . Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma. Medicine (Baltimore). 2019; 98(27):e16386. PMC: 6635253. DOI: 10.1097/MD.0000000000016386. View

4.
Li N, Du X, Reitzel L, Xu L, Sturgis E . Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid. 2012; 23(1):103-10. PMC: 3539256. DOI: 10.1089/thy.2012.0392. View

5.
Ito Y, Miyauchi A, Oda H . Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials. Eur J Surg Oncol. 2017; 44(3):307-315. DOI: 10.1016/j.ejso.2017.03.004. View